dc.contributor.author | Omar, Muhammad Imran | |
dc.contributor.author | MacLennan, Steven | |
dc.contributor.author | Ribal, Maria Jose | |
dc.contributor.author | Roobol, Monique J | |
dc.contributor.author | Dimitropoulos, Konstantinos | |
dc.contributor.author | van den Broeck, Thomas | |
dc.contributor.author | MacLennan, Sara | |
dc.contributor.author | Evans-Axelsson, Susan | |
dc.contributor.author | Gandaglia, Giorgio | |
dc.contributor.author | Willemse, Peter-Paul M. | |
dc.contributor.author | Mastris, Ken | |
dc.contributor.author | Butler-Ransohoff, John-Edward | |
dc.contributor.author | Devecseri, Zsuzsanna | |
dc.contributor.author | Abbott, Thomas | |
dc.contributor.author | De Meulder, Bertrand | |
dc.contributor.author | Bjartell, Anders | |
dc.contributor.author | Asiimwe, Alex | |
dc.contributor.author | N'Dow, James | |
dc.date.accessioned | 2023-08-21T13:03:07Z | |
dc.date.available | 2023-08-21T13:03:07Z | |
dc.date.issued | 2023-04-03 | |
dc.identifier.citation | Omar , M I , MacLennan , S , Ribal , M J , Roobol , M J , Dimitropoulos , K , van den Broeck , T , MacLennan , S , Evans-Axelsson , S , Gandaglia , G , Willemse , P-P M , Mastris , K , Butler-Ransohoff , J-E , Devecseri , Z , Abbott , T , De Meulder , B , Bjartell , A , Asiimwe , A & N'Dow , J 2023 , ' Unanswered questions in prostate cancer : Findings of an international multi-stakeholder consensus by the PIONEER Consortium ' , Nature reviews. Urology . https://doi.org/10.1038/s41585-023-00748-9 | en |
dc.identifier.issn | 1759-4812 | |
dc.identifier.other | PURE: 221154955 | |
dc.identifier.other | PURE UUID: 19601a3b-d4b6-4866-b4a4-d4b53f4ea226 | |
dc.identifier.other | ORCID: /0000-0003-1405-6964/work/132504456 | |
dc.identifier.other | ORCID: /0000-0002-2691-8421/work/132504607 | |
dc.identifier.other | ORCID: /0000-0002-1597-3126/work/132504764 | |
dc.identifier.other | PubMed: 37012441 | |
dc.identifier.other | Scopus: 85151736991 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/19734 | |
dc.description | Acknowledgements PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint under- taking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nature reviews. Urology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | prostate | en |
dc.subject | Prostate Cancer | en |
dc.subject | R Medicine | en |
dc.subject | European Commission | en |
dc.subject | 777492 | en |
dc.subject.lcc | R | en |
dc.title | Unanswered questions in prostate cancer : Findings of an international multi-stakeholder consensus by the PIONEER Consortium | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1038/s41585-023-00748-9 | |
dc.date.embargoedUntil | 2023-08-20 | |